Serenella Eppenberger-Castori

Institution: Pathologie Universitätspital Basel


Department of Molecular Pathology
Institute for Pathology
Schoenbeinstrasse 40 CH-4031 Basel


Phone: +41 61 328 6820

Selected publications:

Baumhoer Daniel, Brunner Philippe, Eppenberger-Castori Serenella, Smida Jan, Nathrath Michaela, Jundt Gernot. Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK Registry. Oral Oncology 11/2013; 45.

Hirt Christian, Eppenberger-Castori Serenella, Sconocchia Giuseppe, Iezzi Giandomenica, Tornillo Luigi, Terracciano Luigi, Spagnoli Giulio C, Raoul A Droeser Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis. Oncoimmunology. 10/2013; 2(10):e25990.

Andreozzi M, Quagliata L, Gsponer JR, Ruiz C, Vuaroqueaux V, Eppenberger-Castori S, Tornillo L, Terracciano LM. VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities. Angiogenesis. October 2013.

Sadanandam A, Lal A, Benz SC, Eppenberger-Castori S, Scott G, Gray JW, Spellman P, Waldman F, Benz CC. Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells? Breast Cancer Res Treat. 2012 Dec;136(3):693-703

Vuaroqueaux V, Urban P, Labuhn M, Delorenzi M, Wirapati P, Benz CC, Flury R, Dieterich H, Spyratos F, Eppenberger U and Eppenberger-Castori S: Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome. Breast Cancer Res. 2007 May 29, 9:R33 Zhou Y, Yau C, Gray JW, Chew K, Dairkee SH, Moore DH, Eppenberger U, Eppenberger-Castori S, Benz CC: Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. BMC Cancer. 2007;7:59 26.

Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer. J Clin Oncol. 2006 Sep 10;24(26):4245-53

Zanetti-Dallenbach R, Vuaroqueaux V, Wight E, Labuhn M, Singer G, Urban P, Eppenberger U, Holzgreve W, Eppenberger-Castori S. Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples. Breast Cancer Res. Breast Cancer Res. 2006 Aug 18;8(4):R5

Serenella Eppenberger-Castori, Willy Kueng, et al, Prognostic and Predictive Significance of ErbB-2 Breast Tumor Levels Measured by Enzyme-Immuno-Assay (EIA), J Clin Oncol 19:645-656, 2001

Members List